Immunologic changes to autologous transfusion after operational trauma in malignant tumor patients:Neopterin and Interleukin-2

被引:0
|
作者
严敏
陈钢
房玲玲
柳子明
张秀来
机构
[1] China
[2] Zhejiang University
[3] Second Affiliated Hospital
[4] School of Medicine
[5] Department of Anesthesiology
[6] Hangzhou310009
关键词
Autologous transfusion; Allogeneic transfusion; Serum Neopterin; INF-gamma; Immunoloic change;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 ;
摘要
Objective:To estimate the impact of autologous transfusion on the status of perioperative immune activation inmalignant tumor patients.The Serum Neopterin and Interleukin-2(IL-2)were measured.Methods:Sixty patients undergoingelective radical resection for malignant stomach tumor were enrolled in the prospective study and assigned to the following groups:(Ⅰ)Group A received autologous transfusion;(2)Group H received allogeneic transfusion.The perioperative course(Beforeinduction of anesthesia,after operation and 5 d after operation)of Neopterin and IL-2 was compared.Results:In group A,SerumNeopterin was significantly lower than baseline alter operation and IL-2 had no significant changes.In group H,both SerumNeopterin and IL-2 were significantly lower than baseline alter operation and 5 d after operation.Compared with group A,SerumNeopterin was significantly lower than baseline alter operation and 5 d after operation and IL-2 was significantly lower thanbaseline 5 d alter operation.Conchision:Autologous
引用
收藏
页码:51 / 54
页数:4
相关论文
共 50 条
  • [21] Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2
    Shimizu, K
    Fields, RC
    Redman, BG
    Giedlin, M
    Mulé, JJ
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 2000, 6 : S67 - S75
  • [22] PLASMA ELASTASE-ALPHA-1-ANTITRYPSIN, NEOPTERIN, TUMOR NECROSIS FACTOR, AND SOLUBLE INTERLEUKIN-2 RECEPTOR AFTER PROLONGED EXERCISE
    DUFAUX, B
    ORDER, U
    INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1989, 10 (06) : 434 - 438
  • [23] INTERFERON AND INTERLEUKIN-2 INDUCED CHANGES IN TRYPTOPHAN AND NEOPTERIN METABOLISM - POSSIBLE MARKERS FOR BIOLOGICALLY EFFECTIVE DOSES
    DATTA, SP
    BROWN, RR
    BORDEN, EC
    SONDEL, PM
    TRUMP, DL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 338 - 338
  • [24] ELEVATED SERUM LEVELS OF NEOPTERIN AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH OVARIAN-CANCER
    GADDUCCI, A
    FERDEGHINI, M
    MALAGNINO, G
    PRONTERA, C
    FANUCCHI, A
    ANNICCHIARICO, C
    BIANCHI, R
    FIORETTI, P
    FACCHINI, V
    GYNECOLOGIC ONCOLOGY, 1994, 52 (03) : 386 - 391
  • [25] IMMUNOLOGICAL PHENOTYPE OF LYMPHOCYTES IN PATIENTS WITH MALIGNANT-MELANOMA AND ITS CHANGES IN THE COURSE OF INTERLEUKIN-2 IMMUNOTHERAPY
    KADAGIDZE, ZG
    YAVORSKY, VV
    BARYSHNIKOV, AY
    SOLOVYEVA, YA
    SAVELYEVA, YV
    CHEREMUSHKIN, YA
    KOROTKOVA, OV
    VOPROSY ONKOLOGII, 1991, 37 (05) : 544 - 549
  • [26] A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas
    Vey, N
    Blaise, D
    Tiberghien, P
    Attal, M
    Pico, JL
    Reiffers, J
    Harrousseau, JL
    Fiere, D
    Tabilio, A
    Gabus, R
    Brandely, M
    Maraninchi, D
    LEUKEMIA & LYMPHOMA, 1996, 21 (1-2) : 107 - 114
  • [27] Bolus followed by continuous infusion interleukin-2 in patients with metastatic malignant melanoma and kidney cancer previously treated with interleukin-2
    Quan, WDY
    Quan, FM
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (04) : 535 - 538
  • [28] INTERLEUKIN-2 INCREASES THE ANTIBODY-RESPONSE IN PATIENTS RECEIVING AUTOLOGOUS INTRALYMPHATIC TUMOR-CELL VACCINE IMMUNOTHERAPY
    WILLIAMS, TW
    YANAGIMOTO, JM
    MAZUMDER, A
    WISEMAN, CL
    MOLECULAR BIOTHERAPY, 1992, 4 (02) : 66 - 69
  • [29] Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
    Eva Ellebaek
    Trine Zeeberg Iversen
    Niels Junker
    Marco Donia
    Lotte Engell-Noerregaard
    Özcan Met
    Lisbet Rosenkrantz Hölmich
    Rikke Sick Andersen
    Sine Reker Hadrup
    Mads Hald Andersen
    Per thor Straten
    Inge Marie Svane
    Journal of Translational Medicine, 10
  • [30] Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
    Ellebaek, Eva
    Iversen, Trine Zeeberg
    Junker, Niels
    Donia, Marco
    Engell-Noerregaard, Lotte
    Met, Ozcan
    Holmich, Lisbet Rosenkrantz
    Andersen, Rikke Sick
    Hadrup, Sine Reker
    Andersen, Mads Hald
    Straten, Per Thor
    Svane, Inge Marie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10